retatrutide clinical trial retatrutide weight loss Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a Retatrutide—A Game Changer in Obesity

GLP-1 drugs have become a game-changer in treating obesity and type 2 diabetes, forecast to reach a $100 billion market value by 2030

If you're on a GLP-1 medication like Ozempic, Wegovy, or Mounjaro, you're likely experiencing a shiftnot just in your appetite, but in how you think about food, hunger, and nourishment

Inositol and tirzepatide may be used together under medical supervision, but their combined effects on glucose metabolism and insulin sensitivity require careful monitoring

A UNC Health endocrinologist explains the long-term effects on hunger and weight.

Pin now & sip for less

Learn about the dangers these products can pose related to accidental ingestion.